Dr Clynes is studying the biology of a group of hard-to-treat leukaemias. This research could ultimately lead to new treatments to give children with this leukaemia the best chance of survival.
Exploring the role of a novel tumour suppressor in leukaemia
Dr David Clynes
The MRC Weatherall Institute of Molecular Medicine
23 April 2019